N-Terminal Fragment of c-FLIP(L) Processed by Caspase 8 Specifically Interacts with TRAF2 and Induces Activation of the NF-κB Signaling Pathway

REFERENCES

• Alam, A., Cohen L. Y., Aouad S., and Sékaly R. P.. 1999. Early activation of caspases during T lymphocyte stimulation results in selective substrate cleavage in nonapoptotic cells. J. Exp. Med. 190:1879–1890.
   PubMed Web of Science ®Google Scholar
• Alderson, M. R., Armitage R. J., Maraskovsky E., Tough T. W., Roux E., Schooley K., Ramsdell F., and Lynch D. H.. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231–2235.
   PubMed Web of Science ®Google Scholar
• Boatright, K. M., Renatus M., Scott F. L., Sperandio S., Shin H., Pedersen I. M., Ricci J. E., Edris W. A., Sutherlin D. P., Green D. R., and Salvesen G. S.. 2003. A unified model for apical caspase activation. Mol. Cell 11:529–541.
   PubMed Web of Science ®Google Scholar
• Budd, R. C. 2002. Death receptors couple to both cell proliferation and apoptosis. J. Clin. Investig. 109:437–441.
   PubMed Web of Science ®Google Scholar
• Chang, D. W., Xing Z., Pan Y., Algeciras-Schimnich A., Barnhart B. C., Yaish-Ohad S., Peter M. E., and Yang X.. 2002. c-FLIPL is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21:3704–3714.
   PubMed Web of Science ®Google Scholar
• Chaudhary, P. M., Eby M. T., Jasmin A., Kumar A., Liu L., and Hood L.. 2000. Activation of the NF-κB pathway by caspase 8 and its homologs. Oncogene 19:4451–4460.
   PubMed Web of Science ®Google Scholar
• Chun, H. J., Zheng L., Ahmad M., Wang J., Speirs C. K., Siegel R. M., Dale J. K., Puck J., Davis J., Hall C. G., Skoda-Smith S., Atkinson T. P., Straus S. E., and Lenardo M. J.. 2002. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419:395–399.
   PubMed Web of Science ®Google Scholar
• Cryns, V., and Yuan J.. 1998. Proteases to die for. Genes Dev. 12:1551–1570.
   PubMed Web of Science ®Google Scholar
• Devin, A., Cook A., Lin Y., Rodriguez Y., Kelliher M., and Liu Z. G.. 2000. The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12:419–429.
   PubMed Web of Science ®Google Scholar
• Donepudi, M., Sweeney A. M., Briand C., and Grütter M. G.. 2003. Insights into the regulatory mechanism for caspase-8 activation. Mol. Cell 11:543–549.
   PubMed Web of Science ®Google Scholar
• Gaide, O., Favier B., Legler D. F., Bonnet D., Brissoni B., Valitutti S., Bron C., Tschopp J., and Thome M.. 2002. CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-κB activation. Nat. Immunol. 3:836–843.
   PubMedGoogle Scholar
• Ghosh, S., and Karin M.. 2002. Missing pieces in the NF-κB puzzle. Cell 109:S81–S96.
   PubMed Web of Science ®Google Scholar
• Hara, H., Wada T., Bakal C., Kozieradzki I., Suzuki S., Suzuki N., Nghiem M., Griffiths E. K., Krawczyk C., Bauer B., D'Acquisto F., Ghosh S., Yeh W. C., Baier G., Rottapel R., and Penninger J. M.. 2003. The MAGUK family protein CARD11 is essential for lymphocyte activation. Immunity 18:763–775.
   PubMed Web of Science ®Google Scholar
• Hu, W. H., Johnson H., and Shu H. B.. 2000. Activation of NF-κB by FADD, Casper, and caspase-8. J. Biol. Chem. 275:10838–10844.
   PubMed Web of Science ®Google Scholar
• Hua, Z. C., Sohn S. J., Kang C., Cado D., and Winoto A.. 2003. A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Immunity 18:513–521.
   PubMed Web of Science ®Google Scholar
• Irmler, M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J. L., Schröter M., Burns K., Mattmann C., Rimoldi D., French L. E., and Tschopp J.. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190–195.
   PubMed Web of Science ®Google Scholar
• Irmler, M., Steiner V., Ruegg C., Wajant H., and Tschopp J.. 2000. Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis. FEBS Lett. 468:129–133.
   PubMedGoogle Scholar
• Jun, J. E., Wilson L. E., Vinuesa C. G., Lesage S., Blery M., Miosge L. A., Cook M. C., Kucharska E. M., Hara H., Penninger J. M., Domashenz H., Hong N. A., Glynne R. J., Nelms K. A., and Goodnow C. C.. 2003. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18:751–762.
   PubMedGoogle Scholar
• Kataoka, T., Budd R. C., Holler N., Thome M., Martinon F., Irmler M., Burns K., Hahne M., Kennedy N., Kovacsovics K., and Tschopp J.. 2000. The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways. Curr. Biol. 10:640–648.
   PubMed Web of Science ®Google Scholar
• Kelliher, M. A., Grimm S., Ishida Y., Kuo F., Stanger B. Z., and Leder P.. 1998. The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8:297–303.
   PubMed Web of Science ®Google Scholar
• Kennedy, N. J., Kataoka T., Tschopp J., and Budd R. C.. 1999. Caspase activation is required for T cell proliferation. J. Exp. Med. 190:1891–1895.
   PubMed Web of Science ®Google Scholar
• Kim, J. W., Choi E. J., and Joe C. O.. 2000. Activation of death-inducing signaling complex (DISC) by pro-apoptotic C-terminal fragment of RIP. Oncogene 19:4491–4499.
   PubMedGoogle Scholar
• Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407:789–795.
   PubMed Web of Science ®Google Scholar
• Krueger, A., Baumann S., Krammer P. H., and Kirchhoff S.. 2001. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol. Cell. Biol. 21:8247–8254.
   PubMed Web of Science ®Google Scholar
• Krueger, A., Schmitz I., Baumann S., Krammer P. H., and Kirchhoff S.. 2001. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 276:20633–20640.
   PubMed Web of Science ®Google Scholar
• Lee, S. Y., Reichlin A., Santana A., Sokol K. A., Nussenzweig M. C., and Choi Y.. 1997. TRAF2 is essential for JNK but not NF-κB activation and regulates lymphocyte proliferation and survival. Immunity 7:703–713.
   PubMed Web of Science ®Google Scholar
• Lens, S. M. A., Kataoka T., Fortner K. A., Tinel A., Ferrero I., MacDonald R. H., Hahne M., Beermann F., Attinger A., Orbea H. A., Budd R. C., and Tschopp J.. 2002. The caspase 8 inhibitor c-FLIPL modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol. Cell. Biol. 22:5419–5433.
   PubMedGoogle Scholar
• Leo, E., Deveraux Q. L., Buchholtz C., Welsh K., Matsuzawa S., Stennicke H. R., Salvesen G. S., and Reed J. C.. 2001. TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-α-induced apoptosis. J. Biol. Chem. 276:8087–8093.
   PubMed Web of Science ®Google Scholar
• Lin, Y., Devin A., Rodriguez Y., and Liu Z. G.. 1999. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 13:2514–2526.
   PubMed Web of Science ®Google Scholar
• Locksley, R. M., Killeen N., and Lenardo M. J.. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487–501.
   PubMed Web of Science ®Google Scholar
• Martinon, F., Holler N., Richard C., and Tschopp J.. 2000. Activation of a pro-apoptotic amplification loop through inhibition of NF-κB-dependent survival signals by caspase-mediated inactivation of RIP. FEBS Lett. 468:134–136.
   PubMedGoogle Scholar
• Micheau, O., Thome M., Schneider P., Holler N., Tschopp J., Nicholson D. W., Briand C., and Grütter M. G.. 2002. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277:45162–45171.
   PubMedGoogle Scholar
• Nagata, S. 1997. Apoptosis by death factor. Cell 88:355–365.
   PubMed Web of Science ®Google Scholar
• Newton, K., Harris A. W., Bath M. L., Smith K. G. C., and Strasser A.. 1998. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 17:706–718.
   PubMed Web of Science ®Google Scholar
• Newton, K., Kurts C., Harris A. W., and Strasser A.. 2001. Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells. Curr. Biol. 11:273–276.
   PubMedGoogle Scholar
• Nicholson, D. W. 1999. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6:1028–1042.
   PubMed Web of Science ®Google Scholar
• Salmena, L., Lemmers B., Hakem A., Matysiak-Zablocki E., Murakami K., Au P. Y. B., Berry D. M., Tamblyn L., Shehabeldin A., Migon E., Wakeham A., Bouchard D., Yeh W. C., McGlade J. C., Ohashi P. S., and Hakem R.. 2003. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev. 17:883–895.
   PubMed Web of Science ®Google Scholar
• Scaffidi, C., Schmitz I., Krammer P. H., and Peter M. E.. 1999. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 274:1541–1548.
   PubMed Web of Science ®Google Scholar
• Schneider, P., Holler N., Bodmer J. L., Hahne M., Frei K., Fontana A., and Tschopp J.. 1998. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187:1205–1213.
   PubMed Web of Science ®Google Scholar
• Shu, H. B., Halpin D. R., and Goeddel D. V.. 1997. Casper is a FADD- and caspase-related inducer of apoptosis. Immunity 6:751–763.
   PubMed Web of Science ®Google Scholar
• Tada, K., Okazaki T., Sakon S., Kobarai T., Kurosawa K., Yamaoka S., Hashimoto H., Mak T. W., Yagita H., Okumura K., Yeh W. C., and Nakano H.. 2001. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death. J. Biol. Chem. 276:36530–36534.
   PubMed Web of Science ®Google Scholar
• Thome, M., Martinon F., Hofmann K., Rubio V., Steiner V., Schneider P., Mattmann C., and Tschopp J.. 1999. Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-κB transcription factor and c-Jun N-terminal kinase. J. Biol. Chem. 274:9962–9968.
   PubMedGoogle Scholar
• Thome, M., and Tschopp J.. 2001. Regulation of lymphocyte proliferation and death by FLIP. Nat. Rev. Immunol. 1:50–58.
   PubMedGoogle Scholar
• Tibbetts, M. D., Zheng L., and Lenardo M. J.. 2003. The death effector domain protein family: regulators of cellular homeostasis. Nat. Immunol. 4:404–409.
   PubMed Web of Science ®Google Scholar
• Tschopp, J., Irmler M., and Thome M.. 1998. Inhibition of Fas death signals by FLIPs. Curr. Opin. Immunol. 10:552–558.
   PubMed Web of Science ®Google Scholar
• Tsitsikov, E. N., Laouini D., Dunn I. F., Sannikova T. Y., Davidson L., Alt F. W., and Geha R. S.. 2001. TRAF1 is a negative regulator of TNF signaling: enhanced TNF signaling in TRAF1-deficient mice. Immunity 15:647–657.
   PubMed Web of Science ®Google Scholar
• Walsh, C. M., Wen B. G., Chinnaiyan A. M., O'Rourke K., Dixit V. M., and Hedrick S. M.. 1998. A role for FADD in T cell activation and development. Immunity 8:439–449.
   PubMed Web of Science ®Google Scholar
• Yeh, W. C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., de la Pompa J. L., Ferrick D., Hum B., Iscove N., Ohashi P., Rothe M., Goeddel D. V., and Mak T. W.. 1997. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7:715–725.
   PubMed Web of Science ®Google Scholar
• Zhang, J., Cado D., Chen A., Kabra N. H., and Winoto A.. 1998. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 392:296–300.
   PubMed Web of Science ®Google Scholar
• Zörnig, M., Hueber A. O., and Evan G.. 1998. p53-dependent impairment of T cell proliferation in FADD dominant-negative transgenic mice. Curr. Biol. 8:467–470.
   PubMedGoogle Scholar